Education
About Us
Working with TipRanks
Follow Us
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 210.78M | $ 129.01M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 210.78M | $ 129.01M | $ 0.00 | $ 0.00 | $ -326.00K |
| Operating Income | $ 47.01M | $ -3.16M | $ -97.25M | $ -51.13M | $ -26.67M |
| EBITDA | $ 47.01M | $ -321.00K | $ -95.35M | $ -50.01M | $ -26.20M |
| Net Income | $ 65.63M | $ -6.68M | $ -94.62M | $ -51.16M | $ -26.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 420.00M | $ 351.97M | $ 188.71M | $ 291.06M | $ 39.05M |
| Total Assets | $ 526.32M | $ 469.19M | $ 252.06M | $ 305.83M | $ 43.53M |
| Total Debt | $ 59.21M | $ 68.23M | $ 25.94M | $ 0.00 | $ 0.00 |
| Net Debt | $ -42.00M | $ 628.00K | $ -19.22M | $ -291.06M | $ -39.05M |
| Total Liabilities | $ 97.64M | $ 226.83M | $ 39.50M | $ 7.12M | $ 85.02M |
| Stockholders' Equity | $ 428.68M | $ 242.36M | $ 212.55M | $ 298.72M | $ -41.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -44.72M | $ 134.19M | $ -96.67M | $ -55.44M | $ -27.89M |
| Operating Cash Flow | $ -41.56M | $ 139.80M | $ -93.79M | $ -50.86M | $ -25.57M |
| Investing Cash Flow | $ -27.80M | $ -138.40M | $ -148.65M | $ -4.58M | $ -2.32M |
| Financing Cash Flow | $ 102.96M | $ 21.04M | $ 479.00K | $ 307.46M | $ 50.09M |